Stay updated with breaking news from Remunity Pump. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
United Therapeutics (NASDAQ:UTHR – Get Free Report) was upgraded by analysts at StockNews.com from a “buy” rating to a “strong-buy” rating in a note issued to investors on Wednesday. A number of other equities analysts have also recently issued reports on UTHR. UBS Group dropped their target price on United Therapeutics from $330.00 to $310.00 […]
Shares of United Therapeutics Co. (NASDAQ:UTHR – Free Report) have been assigned an average rating of “Moderate Buy” from the nine analysts that are currently covering the stock, MarketBeat reports. Two investment analysts have rated the stock with a sell rating and seven have issued a buy rating on the company. The average 1-year price […]
United Therapeutics Co. (NASDAQ:UTHR – Free Report) – Zacks Research lifted their FY2023 earnings per share estimates for United Therapeutics in a note issued to investors on Monday, July 3rd. Zacks Research analyst K. Shah now anticipates that the biotechnology company will post earnings per share of $17.62 for the year, up from their prior […]
Shares of United Therapeutics Co. (NASDAQ:UTHR – Free Report) have been given a consensus recommendation of “Moderate Buy” by the nine analysts that are presently covering the company, MarketBeat.com reports. Two analysts have rated the stock with a sell rating and seven have given a buy rating to the company. The average 12 month price […]
Shares of United Therapeutics Co. (NASDAQ:UTHR – Free Report) have earned an average rating of “Moderate Buy” from the nine analysts that are covering the firm, MarketBeat Ratings reports. Two equities research analysts have rated the stock with a sell rating and seven have given a buy rating to the company. The average 1-year price […]